Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Somnomed.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Quarterlies: Junior techs and biotechs still thriving despite difficult conditions
News
ASX Quarterlies: Biotechs deliver strong performances for shareholders
Health & Biotech
ASX Health Stocks: Cochlear’s profit down 28pc in first half, as Estia’s aged care struggles with Omicron outbreak
Health & Biotech
ASX Health Stocks: Resapp gains on India COVID-19 trial, Atomo to supply HIV self-test in Australia
Director Trades
Directors’ Trades: As Nuix recovers from last month’s lows, one director made a $501,180 buy
Health & Biotech
ScoPo’s powerplays: It’s been ‘like a waterfall of information’ hitting us daily
Health & Biotech
SomnoMed taps tech for new board hires, posts full-year profit
Experts
Scopo’s powerplays: Investors love a result, until they don’t
News
What ASX investors should look for in a COVID-19 earnings season
Food & Agriculture
Economic recovery post-COVID, the five sectors that will lead the charge
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Experts
Scopo’s powerplays: It just won’t go down!
Health & Biotech
The health stocks still taking a hit from COVID-19
Health & Biotech
Check up: Diarrhoea and the FDA are lifting share prices
Health & Biotech
